Educational Videos

NeoGenomics’ latest educational videos

 

Comparison of PD-L1 Companion, Complementary and Laboratory Developed Tests with Molecular Profiling
NeoGenomics' Dr. Albitar discusses usage of PD-L1 antibodies (PD-L1 22C3, PD-L1 28.8, PD-L1 SP 142, and PD-L1 263), including how results correlated with molecular testing that was performed on the same patient and at the same time. This session was recorded at Immunotherapy World on January 18th, 2017.
Learn more about PD-L1

 Key Topics: PD-L1, Immuno-Oncology

About Dr. Albitar

 

 

 

Universal Fusion/Expression Profile Product Overview: Expanding the Boundaries of Cancer Diagnostics
NeoGenomics' Dr. Albitar speaks about the test benefits & other highlights of the Universal Fusion/Expression Profile.
Learn more about the Universal Fusion/Expression Profile Panel

 Key Topics: Next-Gen Sequencing, Universal Fusion/Expression Profile

About Dr. Albitar

 

 

1
Steven C. Brodie, PhD, FACMG
President, Pharma Services Division
 

 


Dr. Brodie is the President of the Pharma Services division at NeoGenomics. Previously he served as the company’s Chief Scientific Officer and Director of BioPharma Operations, and Director of Molecular and Cytogenetics. Prior to joining NeoGenomics in 2011, Dr. Brodie served as Senior Director of Cytogenetics, Assistant Director of Molecular Genetics, and Scientific Director of Maternal Serum Screening at Specialty Laboratories/Quest Diagnostics in Valencia, CA. Dr. Brodie trained pathology residents in genetic testing at both Loma Linda University Medical Center, where he served as the Affiliate Rotation Director, and University of Southern California, Keck School of Medicine, where he served as a Clinical Assistant Professor of Pathology. Prior to joining Quest Diagnostics, he held a variety of research and clinical positions at the National Institutes of Health, University of New Mexico School of Medicine, and UCLA David Geffen School of Medicine. Dr. Brodie received his genetics training at the UCLA/Cedar-Sinai Medical Center medical genetics training program in Los Angeles, CA. He received his Ph.D. from UNM School of Medicine and completed Clinical Genetics training in Cytogenetics and Molecular Genetics at UCLA. Dr. Brodie is Board Certified by the American Board of Medical Genetics in these specialties and holds Director licenses in Florida, California, and New York. Throughout his career, Dr. Brodie has held various research and clinical positions at the NIH, UNM and UCLA, and comes to us after directing high throughput testing in Cytogenetics, FISH, Molecular Genetics, and Oncology for Quest Diagnostics, Nichols Institute. He is also a CAP approved inspector.

2
Lawrence M. Weiss
Lawrence M. Weiss, MD
Medical Director (Aliso Viejo, California) and Director of Pathology Services

 


Dr. Weiss received his BS summa cum laude and M.D. summa cum laude from the University of Maryland. He completed a residency in Anatomic Pathology at the Brigham and Women’s Hospital and a fellowship in surgical pathology at Stanford University Medical Center. He was previously an Assistant Professor of Pathology at Stanford, President of the Medical Staff, and Chairman of Pathology at the City of Hope. He is the author of over 500 papers and book chapters, as well as over a dozen books, including an AFIP Lymph Node Fascicle, Applied Immunohistochemistry, Lymph Nodes, and Knowles’ Hematopathology. His laboratory discovered the first molecular evidence linking the Epstein-Barr virus with Hodgkin Lymphoma. He has won numerous awards, including the Benjamin Castleman, Arthur Purdy Stout, and the United States-Canadian Academy of Pathology Young Investigator Award, and has delivered more than 250 national and international talks in pathology, including several named lectureships. He is on the editorial board of ten scientific journals, and is a past President of the Los Angeles Society of Pathologists. He has been listed in the book The Best Doctors in America since 1994. Dr. Weiss’s diagnostic interests lie in lymph node pathology, adrenal pathology, solid tumor pathology, and immunohistochemistry.

3
Wayne W. Chen, MD, PhD.
Director of Lymphoma Services and Hematopathologist
 

 


Dr. Chen is board certified in Anatomic Pathology, Clinical Pathology, and Hematopathology. Dr. Chen received his medical degree from Nanjing Medical University, his master’s degree from Peking University Health Science Center, and his Ph.D. from National Institute for Viral Disease Control and Prevention, China CDC. He was a postdoctoral fellow and then senior research associate at The Scripps Research Institute in La Jolla, CA. Dr. Chen completed his residency in Anatomic and Clinical Pathology at University of Arizona, Tucson, and completed his two-year fellowship in Hematopathology with subspecialties in lymphoma and lymph node pathology at NCI, NIH in Bethesda, MD, under Dr. Elaine S. Jaffe. Before joining NeoGenomics Laboratories as Director of Lymphoma Services in 2013, Dr. Chen was a hematopathologist and Associate Medical Director at Integrated Oncology (formerly U.S. Labs), LabCorp for over seven years.

4
Antony Bakke, PhD, D(ABMLI)
Director of Flow Cytometry
 

 


Dr. Bakke received his Ph.D. in biochemistry from Caltech in Pasadena, CA. During a postdoctoral fellowship at the Scripps Clinic and Research Foundation in San Diego, CA he learned flow cytometry on an early BD FACS II. He joined the Rheumatology faculty at the University of Southern California in 1980 and completed research projects on SLE, scleroderma, leprosy and natural killer cells, while directing flow cytometry labs for both the Department of Medicine and the Cancer Center. In 1984, he joined the pathology faculty at Oregon Health & Science University Hospital in Portland, OR. During 27 years at OHSU, Dr. Bakke established both the Clinical Immunology/Flow Cytometry Laboratory in the Pathology Department and the Knight Cancer Institute Core Flow Cytometry Resource. He became a full professor at OHSU and completed research projects involving leukemia, lymphoma, PNH, immune thrombocytopenic purpura, rheumatoid arthritis, bacterial and viral infection. Dr. Bakke became a Diplomate of the American Board of Medical Laboratory Immunology in 2004 and served on the council for the International Clinical Cytometry Society from 2005 to 2010. Dr. Bakke was an early adopter of eight and ten-color flow cytometry and cell sorting for clinical specimens.

5
Ainura Kyshtoobayeva, PhD
Immunohistochemistry Quality Control Director
 

 


Dr. Kyshtoobayeva has more than 20 years of experience in IHC, histology, and FISH. She previously served as a research pathologist at Oncotech where she also held the position of Manager of Histology and IHC. A native of Russia, Dr. Kyshtoobayeva received her medical degree from the Professor N. N. Petrov Research Institute of Oncology, Ministry of Health of the USSR, and was awarded a Ph.D. in Pathology from the Board of the Leningrad State Institute of Continuing Education. In the United States, she completed her fellowship at the Oncology Research Faculty Development Program at the National Institutes of Health, Bethesda, MD. Dr. Kyshtoobayeva has published extensively in the areas of breast, prostate, and colon cancer. Please note that Dr. Kyshtoobayeva is not licensed or providing patient services in California.

6
Maher Albitar,  MD
Senior Vice President, Chief Medical Officer and Director of Research and Development
 

 


Dr. Albitar has served as Chief Medical Officer and Director of Research and Development since 2012. Prior to NeoGenomics, Dr. Albitar served as the Medical Director of Hematopathology and Oncology and Chief of R&D for Hematopathology and Oncology, Quest Diagnostics. Prior to joining Quest Diagnostics, Dr. Albitar held various faculty positions at The University of Texas MD Anderson Cancer Center and rose to the position of tenured Full Professor in the Departments of Leukemia and Laboratory Medicine/Pathology. He held the position of Director of Molecular Laboratory and Leukemia Section at MD Anderson Cancer Center at the time of leaving MD Anderson. Dr. Albitar was trained in Anatomic and Clinical Pathology at Brown University in Providence, RI and in Hematopathology at the University of Pennsylvania. He did his post-doctoral training in Genetics at the Genetic Department of Howard Hughes Medical Institute at the University of Pennsylvania. Dr. Albitar received his medical degree from Damascus Medical School in Damascus, Syria.

8
Wilfredo Blasini, MD
Hematopathologist
 

 


Dr. Wilfredo Blasini is board certified in Anatomic Pathology, Clinical Pathology and Hematopathology by the American Board of Pathology. He received his medical degree from University of Puerto Rico School of Medicine in San Juan, Puerto Rico. Subsequently, he completed a residency in Anatomic and Clinical Pathology and a fellowship in Hematopathology at Jackson Memorial Hospital-University of Miami Miller School of Medicine in Miami, Florida. Prior to joining NeoGenomics Laboratories, he worked as an Associate Hematopathologist at Coral Gables Hospital and Palmetto General Hospital in Miami, Florida and at Florida Cancer Specialists in Fort Myers, Florida. Dr. Blasini has authored several papers in pathology peer-review journals and presented at several national pathology conferences. He is a fellow of the College of American Pathologists.

Showing 0 Comment
9
Armin G. Jegalian, MD, PhD.
Hematopathologist
 

 


Prior to joining NeoGenomics, Dr. Jegalian was a staff physician at the Cleveland Clinic, where she was responsible for a high volume of diverse hematopathology cases and teaching trainees. She worked closely with world-renowned lymphoma pathologist Dr. Elaine S. Jaffe during a hematopathology fellowship at the National Institutes of Health. Dr. Jegalian completed her undergraduate degree, medical degree, and Ph.D. in Molecular Biology (Medical Scientist Training Program), and her four-year pathology residency at University of California, Los Angeles. She is board certified in Anatomic Pathology, Clinical Pathology, and Hematopathology, and has written several well-cited publications.

10
Kim Janatpour, MD, MA
Hematopathologist
 

 


Dr. Janatpour brings more than 20 years of pathology experience to NeoGenomics, most recently in a private laboratory where she was Director of Medical Affairs and Director of Pathologist Research. Dr. Janatpour completed her pathology resident training and Hematopathology fellowship at University of California, Davis Medical Center. She also holds a master’s degree in Clinical Research and she has an extensive background in hematopathology research.

11
Tajinder (TJ) Bisla, MD
Senior Pathologist, PathLogic (West Sacramento, California)
 

 


Dr. Tajinder (TJ) Bisla joined PathLogic in 2016. Prior to joining PathLogic, Dr. Bisla worked at Cellnetix Pathology & Laboratories, a multispecialty hospital-based pathology practice in Seattle, WA. He received his medical degree from SUNY Downstate Medical Center. He completed his residency in anatomic and clinical pathology, and a fellowship in general surgical pathology at University of California, San Diego. He has broad expertise in all areas of surgical pathology and cytopathology including genitourinary, gastrointestinal, liver, lung, breast, gynecologic, thyroid, lymph node, and bone marrow pathology. Dr. Bisla is board certified in Anatomic and Clinical Pathology by the American Board of Pathology.

12
Shi-Ping Jiang, MD, PhD
Hematopathologist and Surgical Pathologist
 

 


Dr. Jiang is board certified in Anatomic Pathology, Clinical Pathology, and Hematopathology. She specialized in Hematology and Oncology in China and Germany. Dr. Jiang completed her residency in pathology at the University of Oklahoma Health Sciences Center and the George Washington University Medical Center. She also completed a fellowship in hematopathology at Scripps Clinic in La Jolla, California. Dr. Jiang has extensive experience in hematopathology and vital skills in surgical pathology and served as the medical director at Tustin Center of Integrated Oncology/ Labcorp, Inc.

13
Jesalyn J. Taylor, MD
Hematopathologist
 

 


Dr. Taylor brings her talent to NeoGenomics after several years as a hematopathologist at a private laboratory in California. Dr. Taylor has a specific interest in quality control and quality assurance. Dr. Taylor completed her pathology resident training at University of South Alabama Medical Center, and her hematopathology fellowship at The Methodist Hospital in Houston, TX.

14
Fan Yang, MD, PhD
Hematopathologist
 

 


Dr. Yang shares more than 25 years of experience in medical research and clinical service with subspecialties in Hematology, Anatomic Pathology and Clinical Pathology. Formerly an Assistant Professor of Pathology at the Medical College of Wisconsin and University of Florida, Dr. Yang received his resident training at Albany Medical Center in New York and a Fellowship of Hematopathology from the City of Hope National Medical Center in Duarte, California.

15
Elvira Milano, MD
Co-Director of Cytopathology, PathLogic (West Sacramento, California)
 

 


Dr. Milano serves as PathLogic’s Co-Director of Cytopathology. Dr. Milano has more than twenty years of cytopathology, surgical pathology, clinical pathology and medical director experience in various hospital settings. She acquired her medical degree from Tulane University, and completed her residency in Anatomic and Clinical Pathology and fellowship in Surgical Pathology at the University of California, San Francisco. She is board certified in Anatomic and Clinical Pathology by the American Board of Pathology.

16
Takako Mitsuhashi MD, PhD
Dermatopathologist and Surgical Pathologist
 

 


Dr. Mitsuhashi is board certified in Anatomic Pathology, Clinical Pathology, and Dermatopathology. Dr. Mitsuhashi received her medical degree from Tokyo Women’s Medical College in Japan, and her Ph.D. from Gunma University, School of Medicine in Maebashi, Japan. She was a post-doctoral fellow at Cardiovascular Research Institute in University of California, San Francisco. Dr. Mitsuhashi completed her residency in University of California, Irvine, and completed her fellowship in Dermatopathology at University of California, Irvine, under Dr. Ronald Barr. She was a clinical instructor in Department of Pathology, University of California Irvine, during 2003 to 2004. Prior to joining NeoGenomics, Dr. Mitsuhashi served as the Associate Medical Director at Integrated Oncology (formerly U.S. Labs) for 11 years.

17
Michael Orejudos, MD
Co-Director of Cytopathology, PathLogic (West Sacramento, California)
 

 


Dr. Orejudos serves as Co-Director of Cytopathology at PathLogic in West Sacramento, California and Chief of Cytopathology and Medical Director of Microbiology at the David Grant U.S. Air Force Medical Center. He received his medical degree from Uniformed Services University of the Health Sciences in Bethesda, Maryland. He completed his transitional internship at Malcolm Grow Medical Center Transitional Internship National Capital Consortium at Andrews AFB, Maryland. Dr. Orejudos completed his pathology residency and cytopathology fellowship at the San Antonio Uniformed Pathology Residency Services Health Education AP/CP Consortium in San Antonio, Texas. He is board certified in Anatomic and Clinical Pathology by the American Board of Pathology and holds a subspecialty certification in Cytopathology.

18
Katherine Unger, MD
Renal Pathologist, PathLogic (West Sacramento, California)
 

 


Dr. Unger has been a renal pathologist at PathLogic in West Sacramento, California since 2002. She earned her medical degree from Wake Forest University in Winston-Salem, North Carolina, and completed her residency in Anatomic and Clinical Pathology at the University of California, Davis, where she also was Chief Resident. She then completed a fellowship in Hematopathology at the University of California, Davis, followed by a renal pathology fellowship at PathLogic. Dr. Unger is board certified in Anatomic and Clinical Pathology and holds a subspecialty certification in Hematopathology from the American Board of Pathology.

19
Michele Hibbard Kempik, PhD, FACMG
Director of Genetics
 

 


Dr. Hibbard was the Director of Genetics at Clarient Diagnostic Services, Inc. for eight years prior to the NeoGenomics acquisition. Previously, she spent six years as Director of Genetics at Irvine-based U.S. Labs and a year at Impath labs in New York. She has been responsible for the launch and direction of the operations of the cytogenetics programs at each of these laboratories and the technical operations of the cytogenetic, FISH, and molecular genetic laboratories. Dr. Hibbard completed her clinical genetics training at Harvard Medical School. She completed her post-doctoral research in the Department of Pathology at Brigham and Women’s Hospital and her thesis research in the Department of Microbiology and Molecular Genetics at the University of California, Irvine. She is board certified by the American Board of Medical Genetics in Clinical Molecular Genetics and Clinical Cytogenetics, and holds California licenses as a Clinical Molecular Genetic Molecular Biologist and Clinical Cytogeneticist. She is a fellow in the American College of Medical Genetics and also holds her New York COQ in Cytogenetics, Oncology, and Molecular Tumor Markers.

21
Naigeng Qin, MD, DABMG, FACMG
Clinical Cytogeneticist
 

 


Dr. Qin is a board certified Clinical Cytogeneticist with over 26 years of experience in Clinical Cytogenetics. Previously, Dr. Qin served as Laboratory Director at Genzyme Genetics, California. After earning her medical degree, Dr. Qin completed a Fellowship at Washington University and an additional year at Yale University in Human Genetics. Subsequently, she received her fellowship training in Clinical Cytogenetics at Georgetown University. Previously, Dr. Qin served as a voluntary faculty member at the University of California, Irvine. Dr. Qin is certified by the New York State Department of Health, by the California Department of Public Health, and is a Fellow of American College of Medical Genetics.

22
Robert A. Schoenfeld, PhD
Molecular Laboratory Supervisor, PathLogic (West Sacramento, California)
 

 


Dr. Schoenfeld is the supervisor of the Molecular Laboratory at NeoGenomics’ PathLogic facility in West Sacramento, CA. Prior to joining PathLogic, he gained more than 22 years of experience in molecular biology performing research and teaching in academic settings. He earned his Ph.D. from the University of Utah, Department of Biology, with a focused study on the gene structure of peptide neurotoxins. Following this, he completed postdoctoral fellowships at the University of California, Davis, first in the Department of Molecular and Cellular Biology studying RNA transcriptional regulation following immune injury, then in the School of Veterinary Medicine, Department of Molecular Biosciences studying transcriptional regulation and pathophysiological changes in Friedreich’s ataxia and other mitochondrial diseases. Following this, he was appointed as a Research Faculty member in the Department of Molecular Biosciences, where he continued this work. Dr. Schoenfeld is certified as a Molecular Biology Technician by the American Society of Clinical Pathology.

Bob Gasparini
Bob Gasparini
Bob Gasparini, MS, CLSp(CG), CLDir
Consultant
 

 


Mr. Gasparini currently serves as a Consultant at NeoGenomics. Previously, he served as Chief Science Officer and on the Board of Directors. He also held the position of President from January 2005 through May 2011. Prior to joining NeoGenomics, Mr. Gasparini was Director of the Genetics Division for US Labs, and prior to that was the Molecular Marketing Manager for Ventana Medical Systems. Prior to Ventana, Mr. Gasparini was the Assistant Director of the Cytogenetics Laboratory for the Prenatal Diagnostic Center, an affiliate of Mass General Hospital. While at the Prenatal Diagnostic Center, Mr. Gasparini was also an Adjunct Professor at Harvard University. Mr. Gasparini is a licensed Clinical Laboratory Director and an accomplished author in the field of Cytogenetics and Fluorescence In-Situ Hybridization (FISH) testing. He received his BS in Biological Sciences from the University of Connecticut and his Master of Health Science from Quinnipiac University in Laboratory Administration.

Shehla Arain
Shehla Arain
Shehla Arain, MD
Hematopathologist
 

 


Dr. Arain joined NeoGenomics in 2016. Dr. Arain is a board-certified pathologist with sub-specialty fellowship training in gastrointestinal pathology and cytopathology. Her professional experience includes roles as Medical Laboratory Director and staff pathologist at Specialized Pathology Laboratories, Centennial Pathologists and Heartland Clinic. Dr. Arain completed training as a Cytopathology Fellow at the University of California, Irvine and as a GI/Liver Pathology Fellow at the David Geffen School of Medicine at University of California, Los Angeles. Dr. Arain has spoken at several conferences and has been involved in several case presentations, research projects and publications.

Jennifer Hummel
Jennifer Hummel
Jennifer Hummel, MD, MPH
Hematopathologist / Molecular Pathologist
 

 


Dr. Hummel joined NeoGenomics as a Hematopathologist / Molecular Pathologist in 2016. Previously, Dr. Hummel served as a Hematopathologist / Molecular Pathologist for Novartis/Genoptix from 2014 to 2016 and Clarient Diagnostic Services from 2012 to 2014. Dr. Hummel completed her Molecular and Genetic Pathology fellowship at University of Pittsburgh Medical Center under Dr. Jeffrey Kant and her Hematopathology fellowship and Pathology residency at University of Michigan. Dr. Hummel obtained her medical degree from Medical College of Wisconsin, her Masters of Public Health in Infectious Diseases and Immunity from University of California, Berkeley and her Bachelors of Science from University of Wisconsin, Madison. Dr. Hummel has contributed to several publications and abstracts in hematopathology and solid tumors. In addition, Dr. Hummel has served as a Certified Inspector for the College of American Pathologists (CAP).

David Morgan
David Morgan
David L. Morgan, MD
Hematopathologist
 

 


Prior to joining NeoGenomics in 2016, Dr. Morgan served as the Medical Director of Flow Cytometry at Pathologists Bio-Medical/medfusion Laboratories in Texas. Prior to this position, Dr. Morgan was Medical Director of Hematopathology at AmeriPath North Texas from 2005 to 2010. From 1996 to 2005, Dr. Morgan occupied multiple positions at Texas Tech University Health Sciences Center, including Director of Hematopathology and Flow Cytometry, and Coordinator of the Pathology Residency Program. Dr. Morgan was a tenured Professor of Anatomic and Clinical Pathology at the time of leaving Texas Tech University. He obtained his medical degree from the University of Texas Southwestern Medical School in 1982. His residency in Anatomic and Clinical Pathology was at Presbyterian/St. Luke's Medical Center in Denver, Colorado. Dr. Morgan is a Fellow of the College of American Pathologists and the American Society for Clinical Pathology.

Josette William Ragheb
Josette William Ragheb
Josette William Ragheb
Josette William Ragheb, MD, PhD
Medical Director, Pharma Services and Hematopathologist
 

 


Dr. William joined NeoGenomics as Medical Director, Pharma Services and Hematopathologist in 2017. She previously served as a general pathologist for multiple laboratories and hospitals, including Quest Diagnostics Nichols Institute and Natividad Medical Center. In addition, Dr. William worked as a Hematopathology Consultant for DAKO/Agilent, and has extensive experience in clinical trials as a researcher for Northwestern University Feinberg School of Medicine. She completed her Hematopathology Fellowship and Anatomic and Clinical Pathology Residency at Northwestern University Feinberg School of Medicine in Chicago, Illinois. Dr. William obtained her medical degree from Ain Shams University and her PhD in Clinical Pathology, Immunology from Cairo University. In addition, Dr. William has spoken nationally and internationally, and has contributed toward several publications.

    Dr. Albitar-PD-L1
    Dr. Albitar-PD-L1